The First Affiliated Hospital Of University Of Science And Technology Of China
Clinical trials sponsored by The First Affiliated Hospital Of University Of Science And Technology Of China, explained in plain language.
-
New Triple-Threat treatment tested for tough rectal cancers
Disease control Not yet recruitingThis study is testing a three-part treatment given before surgery for patients with locally advanced rectal cancer that has a high risk of coming back. The treatment combines chemotherapy, radiation, and an immunotherapy drug (a PD-1 inhibitor) to try to shrink the tumor as much …
Phase: PHASE2 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Race against time: new hope for stroke patients when standard treatment Isn't available
Disease control Not yet recruitingThis study tests whether the clot-busting drug tenecteplase can help stroke patients who arrive at the hospital 4.5 to 24 hours after symptoms begin, when the standard mechanical clot removal procedure isn't available. Researchers will compare giving the drug against standard med…
Phase: PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New hope for stroke patients: drug trial aims to boost brain recovery after clot removal
Disease control Not yet recruitingThis study is testing if adding the drug baricitinib to the standard emergency procedure to remove a large blood clot in the brain helps people recover better from a major stroke. It will involve 750 adults who have had this type of stroke and received the clot-removal treatment.…
Phase: PHASE2, PHASE3 • Sponsor: The First Affiliated Hospital of University of Science and Technology of China • Aim: Disease control
Last updated Mar 09, 2026 14:25 UTC